In a remarkable show of optimism, beloved “Jeopardy’ host Alex Trebek, 78, says that his tumors are shrinking rapidly due to chemotherapy, and that his treatment overall seems to be going well.
Trebek says that he’s going to have to go through a few more rounds of chemotherapy, but that he’s excited about the progress he’s made so far, and that there’s hope he’ll enter into a full remission.
Read MoreAnd that usually includes chemotherapy. "So chemotherapies have a hard time getting in, radiation has a hard time penetrating. Think of pancreatic cancer as an oatmeal raisin cookie and the raisins are actually the cancer cells, and the cookie part is actually all the stroma around it. And imagine having to navigate through all that stroma for a treatment to be able to get into a cell to kill it. So that's why the treatments just really aren't good enough to penetrate the cancer. But we're improving, we're getting better treatments."
In his always grateful and positive way, Trebek also took the time to note to People the help of fans and friends who have supported him throughout the entire process. “I've got a couple million people out there who have expressed their good thoughts, their positive energy directed towards me and their prayers,” he says. “I told the doctors, this has to be more than just the chemo, and they agreed it could very well be an important part of this.”
“I've got a lot of love out there headed in my direction and a lot of prayer, and I will never ever minimize the value of that” he says.
The American Cancer Society estimates that about 56,770 people in the United States will be diagnosed with pancreatic cancer this year alone, and that 45,750 people will die of the disease. The 5-year survival rate for people with pancreatic cancer is 9%.
Trebek also recently said that if chemotherapy goes well, there may be an opportunity for his to use immunotherapy, or drugs which use the patient’s own immune system to attack cancer cells. "If we've managed to get rid of some of the tumors, then it'll be great, and then I can go to immunotherapy, because they've discovered that my cancer is a specific mutation that responds well to certain kinds of immunotherapy," said Trebek in an interview with Canadian news outlet The National.
Learn more about SurvivorNet's rigorous medical review process.